About Me
Dr. Reymundo Lozano, Assistant Professor of Psychiatry, Genetics and Genomic Sciences, and Pediatrics, is a pediatric and adult clinical geneticist with neurodevelopmental and aging research training. He has dedicated his research to better understanding the molecular basis neurodevelopmental disorders including autism and dementia. He will direct the Fragile X Syndrome (FXS) Clinic at Mount Sinai and specializes in the treatment of FXS, Kabuki syndrome, Wiedemann-Steiner syndrome and FOXP1. As a collaborator on several clinical trials in FXS and autism, Dr. Lozano is committed to finding targeted treatments. Dr. Lozano’s health care leadership goals are to create new models for delivering high quality, efficient, and cost-effective care in an increasingly changing environment lead by technological advances in genetics and communication. Dr. Lozano has consulted for genetic laboratories, pharmaceutical companies and other non-profit organizations. In the Department of Psychiatry, Dr. Lozano will be a critical part of the Seaver Autism Center team.
Language
Position
ASSISTANT PROFESSOR | Genetics and Genomic Sciences, ASSISTANT PROFESSOR | Psychiatry, ASSISTANT PROFESSOR | PediatricsHospital Affiliations
About Me
Dr. Reymundo Lozano, Assistant Professor of Psychiatry, Genetics and Genomic Sciences, and Pediatrics, is a pediatric and adult clinical geneticist with neurodevelopmental and aging research training. He has dedicated his research to better understanding the molecular basis neurodevelopmental disorders including autism and dementia. He will direct the Fragile X Syndrome (FXS) Clinic at Mount Sinai and specializes in the treatment of FXS, Kabuki syndrome, Wiedemann-Steiner syndrome and FOXP1. As a collaborator on several clinical trials in FXS and autism, Dr. Lozano is committed to finding targeted treatments. Dr. Lozano’s health care leadership goals are to create new models for delivering high quality, efficient, and cost-effective care in an increasingly changing environment lead by technological advances in genetics and communication. Dr. Lozano has consulted for genetic laboratories, pharmaceutical companies and other non-profit organizations. In the Department of Psychiatry, Dr. Lozano will be a critical part of the Seaver Autism Center team.
Language
Position
ASSISTANT PROFESSOR | Genetics and Genomic Sciences, ASSISTANT PROFESSOR | Psychiatry, ASSISTANT PROFESSOR | PediatricsHospital Affiliations
About Me
Dr. Reymundo Lozano, Assistant Professor of Psychiatry, Genetics and Genomic Sciences, and Pediatrics, is a pediatric and adult clinical geneticist with neurodevelopmental and aging research training. He has dedicated his research to better understanding the molecular basis neurodevelopmental disorders including autism and dementia. He will direct the Fragile X Syndrome (FXS) Clinic at Mount Sinai and specializes in the treatment of FXS, Kabuki syndrome, Wiedemann-Steiner syndrome and FOXP1. As a collaborator on several clinical trials in FXS and autism, Dr. Lozano is committed to finding targeted treatments. Dr. Lozano’s health care leadership goals are to create new models for delivering high quality, efficient, and cost-effective care in an increasingly changing environment lead by technological advances in genetics and communication. Dr. Lozano has consulted for genetic laboratories, pharmaceutical companies and other non-profit organizations. In the Department of Psychiatry, Dr. Lozano will be a critical part of the Seaver Autism Center team.
Language
Position
ASSISTANT PROFESSOR | Genetics and Genomic Sciences, ASSISTANT PROFESSOR | Psychiatry, ASSISTANT PROFESSOR | PediatricsHospital Affiliations
Education
MD, University of Guadalajara
Residency , Pediatrics
Woodhull Medical & Mental Hlt. Ctr.
Fellowship, Medical Genetics
Cedars-Sinai Medical Center
Fellowship, Autism
U of C Davis Medical Center
Certifications
American Board of Pediatrics
Clinical Genetics
Research
Aging, Alzheimer's Disease, Autism, Basal Ganglia, Behavior, Bioinformatics, Brain, Brain Imaging, Developmental Biology, Developmental Neurobiology, Diffusion Tensor Imaging, Drug Design and Discovery, Electrophysiology, GABA, Gene Discovery, Gene Expressions, Gene Regulation, Gene Therapy, Genetics, Genomics, Glutamate (NMDA & AMPA) Receptors, Growth Factors and Receptors, Human Genetics and Genetic Disorders, IGF-1 Receptor, Insulin Receptor, Mental Retardation, Microarray, Neuro-degeneration/protection, Neurobiology, Neuromodulation, Neuroscience, Neurotransmitters, Parkinson's Disease, Prefrontal Cortex, Protein Complexes, Protein Degradation, Protein Folding, Protein Kinases, Protein Phosphatases, Protein Structure/Function, Protein Trafficking & Sorting, Protein Translation, Proteomics, RNA, RNA Splicing & Processing, RNA Transport & Localization, Schizophrenia, Signal Transduction, Synapses, Synaptic Plasticity, Synaptogenesis, Systems Biology, Systems Neuroscience, Transcription Factors, Transgenic Mice, Translation
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Lozano has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Mount Sinai Doctors
Accepting New Patients
